EXCEL试验及其他左主干冠状动脉血运重建随机临床试验的贝叶斯解读
该研究采用贝叶斯方法重新分析EXCEL试验,并系统综述了1996年1月至2020年1月间比较CABG与PCI治疗左主干冠状动脉疾病且随访5年的随机临床试验。当使用原文非劣效设计分析EXCEL数据时,5年主要结局差异为2.8%(95%CI -0.9%至6.5%),超过了预设的4.2%非劣效界值,因此不能拒绝PCI劣效的原假设。贝叶斯分析估计PCI相比CABG增加5年主要结局的 probability 为95%,增加全因死亡率的概率为99%。结合其他3项随机试验的先验信息后,PCI增加死亡率的概率降至85%。
要点
- EXCEL试验按原非劣效设计分析,5年主要结局差异为2.8%(95%CI -0.9%至6.5%),超过预设4.2%非劣效界值,不能拒绝PCI劣效的原假设。
- 贝叶斯分析EXCEL主要结局,估计PCI相比CABG增加5年主要结局的概率为95%,该差异大于每100例治疗患者多1个事件的概率为87%。
- 贝叶斯分析提示EXCEL全因死亡率在PCI组增加的概率为99%,绝对差异超过每100例治疗患者多1例死亡的概率为94%。
- 系统综述识别出另外3项研究同一问题的随机临床试验,纳入这些先验知识后,PCI任何超额死亡率的估计概率降至85%。
- 对于包含再次血运重建的次要复合终点,估计PCI每100例治疗患者至少多4个事件的概率为98%,至少多5个事件的概率为90%。
适用人群与场景
- 左主干冠状动脉疾病患者,来自比较CABG与PCI的随机临床试验,随访5年数据。
研究设计与关键结果
- 研究类型为系统综述与贝叶斯再分析,检索PubMed数据库1996年1月至2020年1月,纳入比较CABG与PCI治疗左主干冠状动脉疾病且随访5年的随机临床试验。
- EXCEL试验按原非劣效设计分析,5年主要结局差异为2.8%(95%CI -0.9%至6.5%),超过预设4.2%非劣效界值,不能拒绝PCI劣效的原假设。
- 贝叶斯分析EXCEL主要结局,估计PCI相比CABG增加5年主要结局的概率为95%,差异大于每100例治疗患者多1个事件的概率为87%。
- 贝叶斯分析提示EXCEL全因死亡率在PCI组增加的概率为99%,绝对差异超过每100例治疗患者多1例死亡的概率为94%。
- 系统综述识别出另外3项随机临床试验,纳入先验知识后,PCI任何超额死亡率的估计概率降至85%。
- 次要复合终点(含再次血运重建)估计PCI每100例治疗患者至少多4个事件的概率为98%,至少多5个事件的概率为90%。
证据类型、等级与局限
- 证据类型为系统综述与贝叶斯再分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论提示,无论是基于EXCEL结果单独分析还是基于现有全部证据,对于左主干冠状动脉疾病患者,PCI与CABG相比与更差的长期结果相关,包括死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patients with left main coronary artery disease have improved outcomes with coronary revascularization compared with medical therapy, but the choice of optimal revascularization technique is unresolved.
OBJECTIVE: To use bayesian methods to analyze the risk differences for patients with left main coronary artery disease randomized to treatment with coronary artery bypass surgery (CABG) compared with those randomized to percutaneous coronary intervention (PCI) in recent randomized clinical trials (RCTs).
DESIGN, SETTING, AND PARTICIPANTS: A systematic review using the PubMed database with the query string "(left main disease) and (PCI or CABG) and (5-year follow-up) and (clinical trial)" identified all RCTs from January 1996 to January 2020 comparing CABG to PCI for treatment of patients with left main coronary artery disease and with 5-year follow-up data. With the use of bayesian methods, the largest and most publicized RCT (EXCEL; Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization; 2019) was reanalyzed (1) as an isolated entity using noninformative priors and (2) in the context of previous knowledge using informative priors derived from similar trials. Published aggregate data were used with assignments from each trial following the original intention-to-treat principle. Combining EXCEL data with varying levels of prior information using Bayes theorem provided final (posterior) probability distributions for primary and secondary outcomes.
MAIN OUTCOMES AND MEASURES: A composite end point of death, nonfatal myocardial infarction, and stroke was the primary EXCEL outcome and was accordingly the primary outcome for this reanalysis. Secondary analyses were performed for isolated all-cause mortality and for the composite outcome along with repeated revascularization procedures.
RESULTS: When EXCEL data were analyzed using the originally stated noninferiority design, the 5-year primary outcome difference reported (2.8%; 95% CI, -0.9% to 6.5%) exceeded the predefined 4.2% noninferiority margin; thus, the null hypothesis of PCI inferiority could not be rejected. By contrast, the present bayesian analysis of the EXCEL primary outcome estimated 95% probability that the 5-year primary outcome difference was increased with PCI compared with CABG and 87% probability that this difference was greater than 1 extra event per 100 patients treated. Bayesian analyses also suggested 99% probability that EXCEL total mortality was increased with PCI and 94% probability that this absolute difference exceeded 1 extra deaths per 100 treated. A systematic review identified 3 other RCTs that studied the same question. The incorporation of this prior knowledge reduced the estimated probability of any excess mortality with PCI to 85%. For the secondary composite end point, which also included repeated revascularizations, there were estimated probabilities of 98% for at least 4 extra events and of 90% for at least 5 extra events per 100 patients treated with PCI.
CONCLUSIONS AND RELEVANCE: Bayesian analysis assisted in RCT data interpretation and specifically suggested, whether based on EXCEL results alone or on the totality of available evidence, that PCI was associated with inferior long-term results for all events, including mortality, compared with CABG for patients with left main coronary artery disease.
参考来源
- Brophy JM. Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization. JAMA Intern Med. 2020. PMID: 32478838. doi:10.1001/jamainternmed.2020.1647
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。